
ASH 2023 – The science behind the first CAR-T-cell therapy against T-ALL
Key messages In a world-first application of CAR T cell therapy, base-edited T cells were administered for the first time to a patient with relapsed T-cell leukemia. For gene editing, a base editing approach was used to prevent the DNA damage that occurs with other gene-editing methods. A patient with relapsed T-cell leukemia was successfully […]